
Please try another search
Cryofocus Medtech (Shanghai) Co., Ltd., a medical device company, engages in the research and development, manufacture, and sale of cryoablation minimally invasive interventional treatment technology and related medical products in the People’s Republic of China. The company develops products in the areas of vascular interventional therapy for the treatment of atrial fibrillation, hypertension, and other cardiovascular diseases; and natural orifice transluminal endoscopic surgery for the treatment of urinary, respiratory, and digestive diseases. Its products include the Bladder Cryoablation System, a cryotherapy device for the treatment of non-muscle-invasive bladder cancer; the Gastric Cryoablation System, a self-developed cryoablation system indicated for performing cryoablation on gastric tumors to treat gastric cancer; the Esophageal Cryospray System, for intermediate to advanced esophagus cancer; the pulmonary nodule localization needle for CT-guided localization of lung nodules; the endoscopic clip for anastomosis for the closure of soft tissue in the digestive tract; the laparoscopic single-port multichannel access platform for laparoscopic surgery; the Atrial Fibrillation Pulsed Field Ablation System, for paroxysmal atrial fibrillation; the Anti-Gastroesophageal Reflux System, for gastroesophageal reflux disease; and other non-cryotherapy products. It also provides wound retractors for small incision surgery and minimally invasive surgery; ureteral dilation balloon catheters for ureteral stricture; laparoscopic biopsy bags for biopsy; and laparoscopic surgical instruments for laparoscopy applications. Cryofocus Medtech (Shanghai) Co., Ltd. was incorporated in 2013 and is based in Shanghai, the People’s Republic of China.
Name | Age | Since | Title |
---|---|---|---|
Dayong Gao | 64 | 2021 | Independent Non-Executive Director |
Henan Hu | 35 | 2022 | Independent Non-Executive Director |
Wei Liu | 33 | 2020 | CFO, Joint Company Secretary & Executive Director |
Haorong Zhu | 42 | 2020 | Supervisor |
Kejian Li | 54 | 2013 | Executive Chairman of the Board |
Zheng Qin | 66 | 2021 | Independent Non-Executive Director |
Chunsheng Zhao | 51 | 2021 | Non-Executive Director |
Junkang Qiu | 45 | 2018 | Supervisor |
Hsien Tse Liang | 69 | 2021 | Independent Non-Executive Director |
Jun Zhu | 49 | 2020 | GM & Executive Director |
Jiawei Li | 33 | 2023 | Chairperson of the Board of Supervisors |
Shiwen Lv | 55 | 2014 | Non-Executive Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review